118 related articles for article (PubMed ID: 38687542)
21. Effect of Initial Body Mass Index on Survival Outcome of Patients With Acute Leukemia: A Single-Center Retrospective Study.
Heiblig M; Elhamri M; Nicolini FE; Wattel E; Michallet M; Salles G; Thomas X
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S7-13. PubMed ID: 26297282
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of China.
Ding Z; Han MZ; Chen SL; Ma QL; Wei JL; Pang AM; Zhang XY; Liang C; Yao JF; Cao YG; Feng SZ; Jiang EL
Chin Med J (Engl); 2015 Aug; 128(15):2065-71. PubMed ID: 26228220
[TBL] [Abstract][Full Text] [Related]
23. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
[TBL] [Abstract][Full Text] [Related]
24. Obesity in pediatric oncology.
Rogers PC; Meacham LR; Oeffinger KC; Henry DW; Lange BJ
Pediatr Blood Cancer; 2005 Dec; 45(7):881-91. PubMed ID: 16035086
[TBL] [Abstract][Full Text] [Related]
25. Outcome of very late relapse in children with acute lymphoblastic leukemia.
Rizzari C; Valsecchi MG; Aricò M; Miniero R; Messina C; De Rossi G; Testi AM; Mura R; Galimberti S; Biondi A; Locatelli F; Conter V
Haematologica; 2004 Apr; 89(4):427-34. PubMed ID: 15075076
[TBL] [Abstract][Full Text] [Related]
26. Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
Ram R; Storb R; Sandmaier BM; Maloney DG; Woolfrey A; Flowers ME; Maris MB; Laport GG; Chauncey TR; Lange T; Langston AA; Storer B; Georges GE
Haematologica; 2011 Aug; 96(8):1113-20. PubMed ID: 21508120
[TBL] [Abstract][Full Text] [Related]
27. Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol.
Toksvang LN; Als-Nielsen B; Bacon C; Bertasiute R; Duarte X; Escherich G; Helgadottir EA; Johannsdottir IR; Jónsson ÓG; Kozlowski P; Langenskjöld C; Lepik K; Niinimäki R; Overgaard UM; Punab M; Räty R; Segers H; van der Sluis I; Smith OP; Strullu M; Vaitkevičienė G; Wik HS; Heyman M; Schmiegelow K
BMC Cancer; 2022 May; 22(1):483. PubMed ID: 35501736
[TBL] [Abstract][Full Text] [Related]
28. Low socioeconomic status is a strong independent predictor of relapse in childhood acute lymphoblastic leukemia.
Viana MB; Fernandes RA; de Carvalho RI; Murao M
Int J Cancer Suppl; 1998; 11():56-61. PubMed ID: 9876480
[TBL] [Abstract][Full Text] [Related]
29. Real-world outcomes of treatment for acute lymphoblastic leukemia during adolescence in a financially restricted environment: Results at a single center in Latin America.
Jaime-Pérez JC; Jiménez-Castillo RA; Pinzón-Uresti MA; Cantú-Rodríguez OG; Herrera-Garza JL; Marfil-Rivera LJ; Gómez-Almaguer D
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27957789
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of incomplete hematologic count recovery and minimal residual disease on outcome in adult acute lymphoblastic leukemia at the time of second complete response.
Saygin C; Papadantonakis N; Cassaday RD; Liedtke M; Fischer K; Dunn T; Patel BJ; Sobecks R; Kalaycio M; Sekeres MA; Mukherjee S; Gerds AT; Hamilton BK; Carraway HE; Advani AS
Leuk Lymphoma; 2018 Feb; 59(2):363-371. PubMed ID: 28693363
[TBL] [Abstract][Full Text] [Related]
31. Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period.
Thomas X; Danaïla C; Le QH; Sebban C; Troncy J; Charrin C; Lhéritier V; Michallet M; Magaud JP; Fiere D
Leukemia; 2001 Dec; 15(12):1811-22. PubMed ID: 11753600
[TBL] [Abstract][Full Text] [Related]
32. The Impact of Low-Dose Cranial Boost on the Long-Term Outcomes of Adult Patients with High-Risk Acute Lymphoblastic Leukemia Undergoing Total Body Irradiation and Allogeneic Hematopoietic Stem Cell Transplantation.
Famoso JM; Grow JL; Laughlin B; Katsanis E; Stea B
Pract Radiat Oncol; 2019 May; 9(3):e283-e289. PubMed ID: 30578956
[TBL] [Abstract][Full Text] [Related]
33. The negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia.
den Hoed MA; Pluijm SM; de Groot-Kruseman HA; te Winkel ML; Fiocco M; van den Akker EL; Hoogerbrugge P; van den Berg H; Leeuw JA; Bruin MC; Bresters D; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2015 Jan; 100(1):62-9. PubMed ID: 25304613
[TBL] [Abstract][Full Text] [Related]
34. Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation.
Radich J; Gehly G; Lee A; Avery R; Bryant E; Edmands S; Gooley T; Kessler P; Kirk J; Ladne P; Thomas ED; Appelbaum FR
Blood; 1997 Apr; 89(7):2602-9. PubMed ID: 9116308
[TBL] [Abstract][Full Text] [Related]
35. Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission.
Page KM; Labopin M; Ruggeri A; Michel G; Diaz de Heredia C; O'Brien T; Picardi A; Ayas M; Bittencourt H; Vora AJ; Troy J; Bonfim C; Volt F; Gluckman E; Bader P; Kurtzberg J; Rocha V
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1350-1358. PubMed ID: 28438676
[TBL] [Abstract][Full Text] [Related]
36. Obesity and outcome in pediatric acute lymphoblastic leukemia.
Butturini AM; Dorey FJ; Lange BJ; Henry DW; Gaynon PS; Fu C; Franklin J; Siegel SE; Seibel NL; Rogers PC; Sather H; Trigg M; Bleyer WA; Carroll WL
J Clin Oncol; 2007 May; 25(15):2063-9. PubMed ID: 17513811
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of being overweight and obese at diagnosis in children with acute lymphoblastic leukemia.
Aldhafiri FK; McColl JH; Reilly JJ
J Pediatr Hematol Oncol; 2014 Apr; 36(3):234-6. PubMed ID: 24276040
[TBL] [Abstract][Full Text] [Related]
38. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
[TBL] [Abstract][Full Text] [Related]
39. [The Factors Affecting Relapse in Pediatric B-cell Acute Lymphoblastic Leukemia Patients without Prognostic Fusion Genes Following Up for 10 years].
Jiang MY; Gao W; Gao J; Ling J; Pan J; Xiao PF; Lu J; He HL; Wang Y; Li J; Li JQ; Chai YH; Sun YN; Hu SY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):12-17. PubMed ID: 35123597
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of EPS8 is associated with poor prognosis in patients with acute lymphoblastic leukemia.
He YZ; Liang Z; Wu MR; Wen Q; Deng L; Song CY; Wu BY; Tu SF; Huang R; Li YH
Leuk Res; 2015 Jun; 39(6):575-81. PubMed ID: 25843487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
